Dalpiciclib Plus Letrozole and Capecitabine

Clinical trial NCT05469750 · UNKNOWN

Trial details

NCT number: NCT05469750
Sponsor: Fujian Medical University Union Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2022-08-10
Primary completion: 2023-08-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.